Aripiprazole Alter 15 mg orodispersible tablets EFG

Spain
Brand name Aripiprazole Alter 15 mg orodispersible tablets EFG
Form tablets, buccodispersable
Active substance / Dosage
Prescription type Prescription Only Medicine
Registration number 79687
Aripiprazole Alter 15 mg orodispersible tablets EFG tablets, buccodispersable

Patient Information Leaflet

Introduction

Patient Information Leaflet

Aripiprazol Alter 10 mg orodispersible tablets EFG

Aripiprazol Alter 15 mg orodispersible tablets EFG

aripiprazole

Read the entire leaflet carefully before you start taking this medicine, as it contains important information for you.

  • Keep this leaflet as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it may harm them.
  • If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Leaflet contents: 1. What Aripiprazol Alter orodispersible tablets are and what they are used for

  1. What you need to know before taking Aripiprazol Alter orodispersible tablets
  2. How to take Aripiprazol Alter orodispersible tablets
  3. Possible side effects
  4. How to store Aripiprazol Alter orodispersible tablets
  5. Contents of the pack and other information

1. What Aripiprazol Alter orodispersible tablets are and what they are used for

Aripiprazol Alter orodispersible tablets contain the active substance aripiprazole and belong to a group of medicines called antipsychotics. They are used to treat adults and adolescents aged 15 years and older who have an illness characterized by symptoms such as hearing, seeing, or feeling things that do not exist, mistrust, false beliefs, disorganized speech, and emotional and behavioral flatness. People in this condition may also feel depressed, guilty, restless, or tense.

Aripiprazol Alter orodispersible tablets are used to treat adults and adolescents aged 13 years and older who have a disorder characterized by symptoms such as feeling euphoric, having excessive energy, needing much less sleep than usual, speaking very rapidly with racing thoughts, and sometimes severe irritability. In adults, it also prevents this condition in patients who have responded to treatment with Aripiprazol Alter.

2. What you need to know before taking Aripiprazole Alter orodispersible tablets

Do not take Aripiprazole Alter orodispersible tablets

  • if you are allergic to aripiprazole or to any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor before starting treatment with Aripiprazole.

Cases of patients experiencing suicidal thoughts and behaviour have been reported during treatment with aripiprazole. Inform your doctor immediately if you have thoughts or feelings of harming yourself.

Before starting treatment with Aripiprazole, tell your doctor if you have:

  • high blood sugar levels (characterized by symptoms such as excessive thirst, increased urination, increased appetite, and feeling weak) or a family history of diabetes;
  • seizures, as your doctor may wish to monitor you more closely;
  • irregular and involuntary muscle movements, especially in the face;
  • cardiovascular diseases (heart and circulation problems), family history of cardiovascular disease, stroke or mini-stroke (transient ischaemic attack), or abnormal blood pressure;
  • blood clots or a family history of blood clots, as antipsychotics have been associated with blood clot formation;
  • a history of gambling addiction.

If you notice that you are gaining weight, develop unusual movements, experience drowsiness that interferes with your normal daily activities, have difficulty swallowing, or show allergic symptoms, please inform your doctor.

If you suffer from dementia (loss of memory and other mental abilities), you or your caregiver or family member should inform your doctor if you have ever had a stroke or "mini" stroke.

Speak to your doctor immediately if you have thoughts or feelings of harming yourself. Cases of patients experiencing suicidal thoughts and behaviour have been reported during treatment with aripiprazole.

Speak to your doctor immediately if you experience muscle stiffness or numbness with high fever, sweating, altered mental state, or very rapid or irregular heartbeat.

Inform your doctor if you, your family, or caregiver notice that you are developing impulses or urges to behave in an unusual way and are unable to resist the impulse, instinct, or temptation to carry out certain activities that could harm you or others. This is known as impulse control disorder and may include behaviours such as gambling addiction, excessive spending or eating, abnormally high sex drive, or preoccupation with increased sexual thoughts and feelings.

Your doctor may consider adjusting or stopping your dose.

Aripiprazole may cause drowsiness, low blood pressure upon standing, dizziness, and changes in motor function and balance, which could lead to falls. Caution should be exercised, especially if you are an elderly patient or have some degree of physical weakness.

Children and adolescents

Do not use this medicine in children and adolescents under 13 years of age. It is not known whether it is safe and effective in these patients.

Other medicines and Aripiprazole Alter

Tell your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines, including over-the-counter medicines.

Medicines that lower blood pressure: Aripiprazole may enhance the effect of medicines used to lower blood pressure. Be sure to inform your doctor if you are taking any medicine to control your blood pressure.

If you are taking aripiprazole with another medicine, your doctor may need to adjust the dose of aripiprazole or the other medicine. It is especially important to tell your doctor if you are taking:

  • medicines to correct heart rhythm (such as quinidine, amiodarone, flecainide);
  • antidepressants or herbal medicines used to treat depression and anxiety (such as fluoxetine, paroxetine, venlafaxine, St. John's wort);
  • medicines to treat fungal infections (antifungals) (such as ketoconazole, itraconazole);
  • certain medicines to treat HIV infection (such as efavirenz, nevirapine, and protease inhibitors such as indinavir, ritonavir);
  • anticonvulsants used to treat epilepsy (such as carbamazepine, phenytoin, phenobarbital);
  • certain antibiotics used to treat tuberculosis (rifabutin, rifampicin).

These medicines may increase the risk of side effects or reduce the effect of aripiprazole; if you notice any unusual symptoms while taking any of these medicines together with aripiprazole, you must inform your doctor.

Medicines that increase serotonin levels are generally used for conditions including depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), social phobia, migraine, and pain:

  • triptans, tramadol, and tryptophan used for conditions such as depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), social phobia, migraine, and pain;
  • selective serotonin reuptake inhibitors (SSRIs) (such as paroxetine and fluoxetine) used for depression, OCD, panic, and anxiety;
  • other antidepressants (such as venlafaxine and tryptophan) used in severe depression;
  • tricyclic antidepressants (such as clomipramine and amitriptyline) used in depressive disorders;
  • St. John's wort (Hypericum perforatum) used in herbal medicines for mild depression;
  • analgesics (such as tramadol and pethidine) used to relieve pain;
  • triptans (such as sumatriptan and zolmitriptan) used to treat migraine.

These medicines may increase the risk of side effects; if you notice any unusual symptoms while taking any of these medicines together with aripiprazole, you must inform your doctor.

Taking Aripiprazole Alter with food, drinks, and alcohol

This medicine can be taken regardless of meals.

Alcohol consumption should be avoided.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

The following symptoms may occur in newborn babies whose mothers have been treated with aripiprazole during the last trimester of pregnancy (last three months of pregnancy): tremor, muscle stiffness and/or weakness, drowsiness, agitation, breathing problems, and feeding difficulties. If your baby develops any of these symptoms, contact your doctor.

If you are taking aripiprazole, your doctor will discuss with you whether you should breastfeed, considering the benefit of treatment for you and the benefit of breastfeeding for your baby. If you are being treated with aripiprazole, you should not breastfeed. Talk to your doctor about the best way to feed your baby if you are taking this medicine.

Driving and using machines

Dizziness and vision problems (see section 4) may occur during treatment with this medicine. This should be taken into account when maximum attention is required, for example, when driving or operating machinery.

Aripiprazole Alter contains aspartame

Aripiprazole Alter 10 mg orodispersible tablets: This medicine contains 2.970 mg of aspartame per tablet.

Aripiprazole Alter 15 mg orodispersible tablets: This medicine contains 4.455 mg of aspartame per tablet.

Aspartame is a source of phenylalanine, which may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body cannot properly eliminate it.

3. How to take Aripiprazole Alter orodispersible tablets

Follow exactly the instructions for use of this medicine as given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

The recommended dose for adults is 15 mg once daily. However, your doctor may prescribe lower or higher doses, up to a maximum of 30 mg once daily.

Use in children and adolescents

This medicine should be initiated with the oral solution (liquid) at a low dose. The dose may then be gradually increased to the recommended dose for adolescents of 10 mg once daily. However, your doctor may prescribe lower or higher doses, up to a maximum of 30 mg once daily.

If you feel that the effect of aripiprazole is too strong or too weak, inform your doctor or pharmacist.

Try to take Aripiprazole Alter at the same time each day. It does not matter whether you take it with or without food.

Do not open the blister pack until you are ready to take the tablet. To take a tablet, open the packaging and peel back the aluminum foil from the blister so that the tablet becomes visible. Do not push the tablet through the foil, as this may damage it. Once the blister is opened, with dry hands, take the tablet and place the complete orodispersible tablet on the tongue. The tablet disintegrates rapidly in saliva. The orodispersible tablet may be taken with or without liquid.

Alternatively, the tablet may be dissolved in water and the resulting suspension drunk.

Even if you feel better , do not change or stop your daily dose of Aripiprazole Alter without first consulting your doctor.

If you take more Aripiprazole Alter orodispersible tablets than you should

If you realize that you have taken more Aripiprazole Alter than your doctor has prescribed (or if someone else has taken part of your Aripiprazole Alter), contact your doctor immediately. If you cannot reach your doctor, go to the nearest hospital and take the packaging with you.

Patients who have taken too much aripiprazole have experienced the following symptoms:

  • rapid heartbeat, agitation/aggression, speech problems.
  • unusual movements (especially of the face or tongue), and decreased level of consciousness.

Other symptoms may include:

  • acute confusion, seizures (epilepsy), coma, a combination of fever, rapid breathing, sweating;
  • muscle rigidity and drowsiness, slower breathing, suffocation, high or low blood pressure, abnormal heart rhythms.

Contact your doctor or nearest hospital immediately if you experience any of the symptoms listed above.

If you forget to take Aripiprazole Alter orodispersible tablets

If you forget a dose, take it as soon as you remember. However, do not take a double dose to make up for the forgotten dose.

If you stop taking Aripiprazole Alter orodispersible tablets

Do not stop your treatment just because you feel better. It is important that you continue taking Aripiprazole Alter for as long as your doctor has instructed.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

Common adverse effects (may affect up to 1 in 10 patients):

  • diabetes mellitus;
  • sleep disturbances;
  • anxiety;
  • feeling of restlessness and inability to stay still, difficulty remaining seated;
  • akathisia (an uncomfortable sensation of inner restlessness and an urgent need to keep moving);
  • uncontrollable twisting, writhing, or spasmodic movements, restless legs;
  • tremor;
  • headache;
  • fatigue;
  • somnolence;
  • dizziness;
  • shakiness and blurred vision;
  • difficulty defecating or reduced frequency of bowel movements (constipation);
  • indigestion;
  • nausea;
  • increased saliva production;
  • vomiting;
  • feeling of tiredness.

Uncommon adverse effects (may affect up to 1 in 100 patients):

  • increased or decreased levels of the hormone prolactin in the blood;
  • excessively high blood sugar levels;
  • depression;
  • altered or increased sexual interest;
  • uncontrollable movements of the mouth, tongue, and limbs (tardive dyskinesia);
  • muscular disorder causing twisting movements (dystonia);
  • restless legs;
  • double vision;
  • ocular photosensitivity;
  • rapid heartbeat;
  • drop in blood pressure upon standing, causing dizziness, lightheadedness, or fainting;
  • hiccups.

The following adverse effects have been reported during the post-marketing phase of oral aripiprazole, but their frequency is unknown:

  • low white blood cell count;
  • low platelet count;
  • allergic reaction (e.g., swelling of the mouth, tongue, face, and throat, itching, and redness);
  • onset or worsening of diabetes, ketoacidosis (ketones in blood and urine), or coma;
  • elevated blood sugar;
  • low sodium levels in blood;
  • loss of appetite (anorexia);
  • weight loss;
  • weight gain;
  • suicidal thoughts, suicide attempt, and suicide;
  • aggression;
  • agitation;
  • nervousness;
  • combination of fever, muscle rigidity, rapid breathing, sweating, decreased consciousness, sudden changes in blood pressure and heart rate, and fainting (neuroleptic malignant syndrome);
  • seizures;
  • serotonin syndrome (a reaction that may cause intense feelings of happiness, drowsiness, clumsiness, restlessness, feeling drunk, fever, sweating, or muscle rigidity);
  • speech disorder;
  • fixed eye position (oculogyric crisis);
  • unexplained sudden death;
  • potentially life-threatening irregular heartbeat;
  • heart attack;
  • slower heartbeat;

•blood clots in the veins, especially in the legs (symptoms include swelling, pain, and redness of the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty breathing (if you notice any of these symptoms, contact your doctor immediately);

  • elevated blood pressure;
  • fainting;
  • accidental inhalation of food with risk of pneumonia (lung infection);
  • muscle spasms around the glottis (a part of the larynx);
  • inflammation of the pancreas;
  • difficulty swallowing;
  • diarrhea;
  • abdominal discomfort;
  • stomach upset;
  • liver failure;
  • inflammation of the liver;
  • yellowing of the skin and whites of the eyes (jaundice);
  • abnormal liver function test results;
  • rash;
  • skin photosensitivity;
  • hair loss;
  • excessive sweating;
  • severe allergic reactions, such as drug reaction with eosinophilia and systemic symptoms (DRESS syndrome). DRESS syndrome initially presents as flu-like symptoms with a facial rash, followed by generalized rash, high fever, swollen lymph nodes, increased liver enzyme levels observed in blood tests, and increased levels of a type of white blood cell (eosinophilia);
  • abnormal breakdown of muscle tissue that may lead to kidney problems;
  • muscle pain;
  • stiffness;
  • involuntary loss of urine (incontinence);
  • difficulty urinating;
  • withdrawal symptoms in newborns due to exposure to medication during pregnancy;
  • prolonged and/or painful erection;
  • difficulty controlling core body temperature or overheating;
  • chest pain;
  • swollen hands, ankles, or feet;
  • in blood tests: increased or fluctuating blood sugar levels, increased glycated hemoglobin;
  • inability to resist the impulse, instinct, or temptation to perform an action that could be harmful to yourself or others, which may include:
  • strong urge to gamble excessively despite serious personal or family consequences;

  • altered or increased sexual interest and behavior that is concerning to you or others, for example, increased sexual drive;

  • uncontrollable excessive shopping;

  • binge eating (consuming large amounts of food in a short period of time) or compulsive eating (eating more food than normal and more than needed to satisfy hunger);

  • tendency to wander.

Inform your doctor if you experience any of these behaviors; they will explain how to manage or reduce the symptoms.

In elderly patients with dementia, an increased number of fatal cases have been reported while taking aripiprazole. Additionally, cases of stroke or "mini" strokes have been reported.

Other adverse effects in children and adolescents

Adolescents aged 13 years or older experienced adverse effects similar in frequency and type to those in adults, except for somnolence, uncontrollable spasms or contractions, restlessness, and fatigue, which were very common (affects more than 1 in 10 patients), and upper abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle fasciculations, involuntary limb movements, and dizziness—especially upon standing up from lying or sitting down—which were common (affects up to 1 in 10 patients).

Reporting of adverse effects

If you experience any adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicinal Products: https://www.notificaRAM.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Conservation of Aripiprazole Alter orodispersible tablets

Keep this medicine out of the sight and reach of children.

Store in the original packaging to protect it from moisture.

Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month indicated.

Medicines must not be disposed of via wastewater or household waste. Dispose of empty containers and unused medicines at a SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of containers and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Aripiprazole Alter

  • The active substance is aripiprazole. Each orodispersible tablet contains 10 mg or 15 mg of aripiprazole.
  • The other components are maltose, microcrystalline cellulose, colloidal silicon dioxide, crospovidone, aspartame, ethyl vanillin, red iron oxide (E172) (Aripiprazole Alter 10 mg), yellow iron oxide (E172) (Aripiprazole Alter 15 mg), and magnesium stearate.

Appearance of the product and contents of the pack

Aripiprazole Alter 10 mg is presented as pink, round, flat, un-scored orodispersible tablets.

Aripiprazole Alter 15 mg is presented as yellow, round, biconvex, un-scored orodispersible tablets.

Each pack contains 14 or 28 tablets packed in blisters made of polyamide/Al/PVC-Al.

Only certain pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Laboratorios Alter, S.A.

Mateo Inurria, 30

28036 Madrid

Spain

Date of the most recent review of this leaflet: March 2023

Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/